mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |